The Division for Cardiovascular Pharmacology (CVP) serves members with
interests in all aspects of cardiovascular pharmacology research from
the molecular level to whole animal and clinical studies. Specific areas
include, but are not limited to, mechanisms of cardiovascular drug
action, autonomic pharmacology, cell signaling, cardiac pharmacology,
endothelial and smooth muscle cell pharmacology, hemostasis and
thrombosis, blood vessel wall interactions, and mechanisms involved in
the pathogenesis, diagnosis and treatment of cardiac, renal, pulmonary
and cerebral vascular disease, including hypertension, coronary artery
disease and stroke.
- To promote discovery, dissemination of knowledge, and advances in the field of cardiovascular pharmacology.
- To increase communication among members of the CVP Division.
- To meet at the annual Experimental Biology meeting to discuss past
accomplishments of the division and share future ideas and directions
that are important to cardiovascular pharmacology.
- To promote and strengthen collaboration and connections between the
CVP Division and other ASPET divisions as well as with other national
societies such as FASEB and The American Physiological Society.
- To foster professional development by encouraging CVP Division
trainees and faculty to take an active role on committees and symposia
- To recognize member achievements in division public announcements and through active awards programs
Posting on social media about the CVP division? Use #ASPETCVP.
Last Updated: June 6, 2019